CHIPI, ELENA
 Distribuzione geografica
Continente #
NA - Nord America 225
EU - Europa 175
AS - Asia 140
SA - Sud America 1
Totale 541
Nazione #
US - Stati Uniti d'America 225
IE - Irlanda 81
IT - Italia 70
HK - Hong Kong 61
SG - Singapore 26
CN - Cina 22
VN - Vietnam 18
KR - Corea 7
RU - Federazione Russa 5
FI - Finlandia 4
SE - Svezia 3
UA - Ucraina 3
AT - Austria 2
DE - Germania 2
FR - Francia 2
IR - Iran 2
TR - Turchia 2
BR - Brasile 1
GB - Regno Unito 1
JP - Giappone 1
NL - Olanda 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 541
Città #
Chandler 79
Dublin 78
Hong Kong 60
Perugia 23
Dong Ket 18
San Mateo 15
Singapore 14
Medford 12
Princeton 11
Altamura 9
Lawrence 9
Boardman 7
Los Angeles 7
Seoul 7
Rome 6
Ashburn 5
Wilmington 5
Bologna 4
Andover 3
Duino-Aurisina 3
Saronno 3
Cinisello Balsamo 2
Izmir 2
Lappeenranta 2
Massarosa 2
Milan 2
New York 2
Saint Petersburg 2
San Paolo di Civitate 2
Vienna 2
Beijing 1
Chiaravalle 1
Curitiba 1
Helsinki 1
Hsinchu 1
Leawood 1
Nagold 1
Norwalk 1
Osimo 1
Shanghai 1
Stockholm 1
Totale 407
Nome #
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia 58
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults 56
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 53
The Italian version of cognitive function instrument (CFI): reliability and validity in a cohort of healthy elderly 46
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine 43
Cognitive impairment in multiple sclerosis: lessons from cerebrospinal fluid biomarkers 41
Clinical and Instrumental Characterization of Patients With Late-Onset Epilepsy 32
The possible role of Optical Coherence Tomography (OCT) and OCT‐Angiography (OCTA) as new non‐invasive biomarkers of prodromal Alzheimer’s disease 31
Characteristics of subjective cognitive decline associated with amyloid positivity 28
Insights into the pathophysiology of psychiatric symptoms in central nervous system disorders: Implications for early and differential diagnosis 26
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum 25
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 24
Chronotype is associated with affective temperaments, clinical severity and worse treatment outcomes in bipolar disorders: results from a two-center, cross-sectional study 21
Educational interventions to improve detection and management of cognitive decline in primary care-An Italian multicenter pragmatic study 17
Clinical correlates of state and trait anxiety in multiple sclerosis 17
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairment 15
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 12
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD 11
Trajectories of CSF and plasma biomarkers across Alzheimer's disease continuum: Disease staging by NF-L, p-tau181, and GFAP 8
Predictive value for cerebrospinal fluid Alzheimer's disease profile of different measures of verbal episodic memory in patients with MCI 6
Totale 570
Categoria #
all - tutte 3.186
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.186


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 1 0
2020/202140 0 2 0 0 9 3 1 0 6 0 0 19
2021/202267 0 11 1 0 0 2 0 16 7 3 14 13
2022/2023258 12 45 1 21 14 20 4 13 108 3 11 6
2023/2024184 13 17 6 5 1 0 47 2 21 12 30 30
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 570